Skip to Content
Merck
CN
  • The fusion partner specifies the oncogenic potential of NUP98 fusion proteins.

The fusion partner specifies the oncogenic potential of NUP98 fusion proteins.

Leukemia research (2013-10-05)
Jesslyn Saw, David J Curtis, Damian J Hussey, Alexander Dobrovic, Peter D Aplan, Christopher I Slape
ABSTRACT

NUP98 is among the most promiscuously translocated genes in hematological diseases. Among the 28 known fusion partners, there are two categories: homeobox genes and non-homeobox genes. The homeobox fusion partners are well-studied in animal models, resulting in HoxA cluster overexpression and hematological disease. The non-homeobox fusion partners are less well studied. We created transgenic animal models for three NUP98 fusion genes (one homeobox, two non-homeobox), and show that in this system, the NUP98-homeobox fusion promotes self-renewal and aberrant gene expression to a significantly greater extent. We conclude that homeobox partners create more potent NUP98 fusion oncogenes than do non-homeobox partners.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Topoisomerase I human, buffered aqueous glycerol solution, ≥2 units/μL